HBI
58
3
BK
74
3
PGR
59
-3
CSCO
58
-2
GOOGL
48
-5
LH
40
-5
SE
60
-3
CMI
64
-3
VRTX
47
-6
MTB
65
-2
WDC
37
-3
RRC
52
-6
STX
45
-4
RHI
57
-6
WU
24
4
EMR
71
-3
O
17
-13
PSA
56
3
ZBH
65
3
ALLE
37
-4
HBI
58
3
BK
74
3
PGR
59
-3
CSCO
58
-2
GOOGL
48
-5
LH
40
-5
SE
60
-3
CMI
64
-3
VRTX
47
-6
MTB
65
-2
WDC
37
-3
RRC
52
-6
STX
45
-4
RHI
57
-6
WU
24
4
EMR
71
-3
O
17
-13
PSA
56
3
ZBH
65
3
ALLE
37
-4
Financhill
Back

Harvest Balanced Income & Growth ETF A Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
14

HBIG.TO
Harvest Balanced Income & Growth ETF A

Last Price:
24.58
Seasonality Move:
--
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
14
Harvest Balanced Income & Growth ETF A (HBIG.TO) is a Sell

Is Harvest Balanced Income & Growth ETF A a Buy, Sell or Hold?

  • The current Harvest Balanced Income & Growth ETF A [HBIG.TO] share price is $24.58. The Score for HBIG.TO is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • HBIG.TO is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

HBIG.TO Stock Price Chart

What is Harvest Balanced Income & Growth ETF A's stock price today?

  • The Harvest Balanced Income & Growth ETF A share price today is $24.58
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HBIG.TO is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

HBIG.TO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 42.42 Sell
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (24.56 - 25.02) Sell
Bollinger Bands (100): (24.38 - 25) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

HBIG.TO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.64 Sell
20-day SMA: 24.73 Sell
50-day SMA: 24.87 Sell
200-day SMA: 0 Buy
8-day EMA: 24.66 Sell
20-day EMA: 24.72 Sell
50-day EMA: 24.77 Sell
200-day EMA: 5.09 Buy

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Harvest Balanced Income & Growth ETF A Earnings Growth & HBIG.TO Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Harvest Balanced Income & Growth ETF A Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):